Publications by authors named "Ann Strange"

Claim this Profile
A
A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
Ankita Mitra, Brian Thompson, Ann Strange, Carol M Amato, Melinda Vassallo

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
Brian Thompson, Ann Strange, Carol M Amato, Jonathan Hester-McCullough, Amod A Sarnaik

J Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, Zeynep Eroglu, Younchul Kim, Ann Strange

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhenoComb: a discovery tool to assess complex phenotypes in high-dimensional single-cell datasets.
Paulo E P Burke, Ann Strange, Emily Monk, Brian Thompson, Carol M Amato

Bioinform Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis